BR0007553A - Derivados de 2,3-o-isopropilideno demonossacarìdeos com atividade inibidora deaderência celular - Google Patents

Derivados de 2,3-o-isopropilideno demonossacarìdeos com atividade inibidora deaderência celular

Info

Publication number
BR0007553A
BR0007553A BR0007553-1A BR0007553A BR0007553A BR 0007553 A BR0007553 A BR 0007553A BR 0007553 A BR0007553 A BR 0007553A BR 0007553 A BR0007553 A BR 0007553A
Authority
BR
Brazil
Prior art keywords
isopropylidene
derivatives
present
monosaccharide
compounds
Prior art date
Application number
BR0007553-1A
Other languages
English (en)
Portuguese (pt)
Inventor
Sudershan Arora
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Publication of BR0007553A publication Critical patent/BR0007553A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
    • C07H9/04—Cyclic acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
BR0007553-1A 1999-01-15 2000-01-10 Derivados de 2,3-o-isopropilideno demonossacarìdeos com atividade inibidora deaderência celular BR0007553A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN86DE1999 IN190975B (enExample) 1999-01-15 1999-01-15
US09/276,368 US6590085B1 (en) 1999-01-15 1999-03-25 Derivatives of monosaccharides as cell adhesion inhibitors
PCT/IB2000/000022 WO2000042054A1 (en) 1999-01-15 2000-01-10 2,3-o-isopropylidene derivatives of monosaccharides as cell adhesion inhibitors

Publications (1)

Publication Number Publication Date
BR0007553A true BR0007553A (pt) 2001-12-18

Family

ID=11088155

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0007553-1A BR0007553A (pt) 1999-01-15 2000-01-10 Derivados de 2,3-o-isopropilideno demonossacarìdeos com atividade inibidora deaderência celular

Country Status (30)

Country Link
US (5) US6590085B1 (enExample)
EP (1) EP1147119B1 (enExample)
JP (1) JP2002534530A (enExample)
CN (1) CN1167707C (enExample)
AR (1) AR022235A1 (enExample)
AT (1) ATE250074T1 (enExample)
AU (1) AU768511B2 (enExample)
BG (1) BG105745A (enExample)
BR (1) BR0007553A (enExample)
CA (1) CA2359986A1 (enExample)
CO (1) CO5180591A1 (enExample)
CR (1) CR6423A (enExample)
CZ (1) CZ20012540A3 (enExample)
DE (1) DE60005300T2 (enExample)
DK (1) DK1147119T3 (enExample)
ES (1) ES2206176T3 (enExample)
HR (1) HRP20010529B1 (enExample)
HU (1) HUP0105116A3 (enExample)
ID (1) ID30351A (enExample)
IN (1) IN190975B (enExample)
MA (1) MA25342A1 (enExample)
MX (1) MXPA01007187A (enExample)
MY (1) MY121135A (enExample)
NZ (2) NZ527483A (enExample)
PA (1) PA8489901A1 (enExample)
PT (1) PT1147119E (enExample)
SK (1) SK284241B6 (enExample)
TR (1) TR200102043T2 (enExample)
WO (1) WO2000042054A1 (enExample)
YU (1) YU50701A (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN190975B (enExample) * 1999-01-15 2003-09-06 Ranbaxy Lab Ltd
NZ577031A (en) 2003-05-30 2010-09-30 Ranbaxy Lab Ltd Substituted pyrrole derivatives and their use as HMG-CO inhibitors
WO2006024926A1 (en) * 2004-09-02 2006-03-09 Ranbaxy Laboratories Limited Monosaccharide derivatives
US20100113371A9 (en) * 2004-12-22 2010-05-06 Ranbaxy Laboratories Limited Inc. Derivatives Of Pentose Monosaccharides As Anti-Inflammatory Compounds
US20090054519A1 (en) * 2005-07-22 2009-02-26 Abhijit Ray Derivatives of monosaccharides as 5-lipoxygenase inhibitors
WO2007054896A1 (en) * 2005-11-08 2007-05-18 Ranbaxy Laboratories Limited Process for (3r, 5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
TW200744583A (en) * 2006-03-14 2007-12-16 Ranbaxy Lab Ltd Statin stabilizing dosage formulations
EP1842855A3 (en) * 2006-03-29 2007-12-05 Ranbaxy Laboratories Limited Monosaccharide derivatives as anti-inflammatory and/or anti-cancer agents
US7790689B2 (en) * 2006-05-30 2010-09-07 Ranbaxy Laboratories Limited Monosaccharide derivatives
EP1953170A1 (en) * 2006-10-03 2008-08-06 Ranbaxy Laboratories Limited Monosaccharide derivatives as anti-inflammatory agents
AU2008221506B2 (en) * 2007-09-20 2011-01-20 ResMed Pty Ltd Retractable Tube for CPAP

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2715121A (en) 1950-09-09 1955-08-09 American Home Prod Alkyl sugar derivatives and their preparation
US4056322A (en) 1973-12-14 1977-11-01 Strategic Medical Research Corporation Preparation of ethers of monosaccharides
US4735934A (en) 1981-02-17 1988-04-05 Greenwich Pharmaceuticals Incorporated Method of therapeutically treating a warm blooded animal afflicted with an autoimmune disease
US4996195A (en) 1989-01-09 1991-02-26 Greenwich Pharmaceuticals Inc. Derivatives of α,D-glucofuranose or α,D-allofuranose and intermediates for preparing these derivatives
US5010058A (en) 1989-06-22 1991-04-23 501 Greenwich Pharmaceuticals Incorporated 3,5,6-substituted derivatives of 1,2-O-isopropylidene-α,D-glucofuranose and intermediates for preparing these derivatives
FR2652540B1 (fr) 1989-10-02 1995-06-02 Imaje Sa Circuit d'encre notamment destine a la mise en pression d'une encre a pigments pour imprimante a jet d'encre.
US5192746A (en) 1990-07-09 1993-03-09 Tanabe Seiyaku Co., Ltd. Cyclic cell adhesion modulation compounds
US5258402A (en) 1992-06-11 1993-11-02 Mcneil-Ppc, Inc. Imidate derivatives of pharmaceutically useful anticonvulsant sulfamates
US5432163A (en) 1992-11-13 1995-07-11 Greenwich Pharmaceuticals Incorporated Anti-proliferative and anti-inflammatory compounds: derivatives of pentose monosaccharides
US5637570A (en) * 1995-05-09 1997-06-10 Chemora Pharmochem Disubstituted and trisubstituted derivatives of 2,3:4,6-di-O-isopropylidene-α-L-xylo-2-hexulofuranosonic acid having anti-cancer, anti-inflammatory and anti-proliferative activity
IN190975B (enExample) * 1999-01-15 2003-09-06 Ranbaxy Lab Ltd

Also Published As

Publication number Publication date
CO5180591A1 (es) 2002-07-30
MA25342A1 (fr) 2001-12-31
IN190975B (enExample) 2003-09-06
CN1343213A (zh) 2002-04-03
NZ527483A (en) 2005-02-25
US20040029820A1 (en) 2004-02-12
TR200102043T2 (tr) 2001-11-21
HRP20010529A2 (en) 2002-08-31
SK10132001A3 (sk) 2002-01-07
ID30351A (id) 2001-11-22
AU1886100A (en) 2000-08-01
BG105745A (en) 2002-05-31
EP1147119A1 (en) 2001-10-24
NZ512852A (en) 2004-02-27
US6590085B1 (en) 2003-07-08
CN1167707C (zh) 2004-09-22
ATE250074T1 (de) 2003-10-15
US7005516B2 (en) 2006-02-28
US20040018995A1 (en) 2004-01-29
YU50701A (sh) 2005-06-10
DE60005300T2 (de) 2004-07-15
CZ20012540A3 (cs) 2002-02-13
ES2206176T3 (es) 2004-05-16
SK284241B6 (en) 2004-11-03
AR022235A1 (es) 2002-09-04
US7037899B2 (en) 2006-05-02
DE60005300D1 (de) 2003-10-23
AU768511B2 (en) 2003-12-18
MXPA01007187A (es) 2002-04-24
CR6423A (enExample) 2004-03-09
HRP20010529B1 (en) 2005-02-28
JP2002534530A (ja) 2002-10-15
US20040023900A1 (en) 2004-02-05
HUP0105116A2 (hu) 2003-04-28
MY121135A (en) 2005-12-30
HUP0105116A3 (en) 2003-05-28
US7005422B2 (en) 2006-02-28
WO2000042054A1 (en) 2000-07-20
PT1147119E (pt) 2004-02-27
PA8489901A1 (es) 2000-09-29
EP1147119B1 (en) 2003-09-17
US20040019191A1 (en) 2004-01-29
CA2359986A1 (en) 2000-07-20
DK1147119T3 (da) 2004-01-19
HK1041270A1 (en) 2002-07-05

Similar Documents

Publication Publication Date Title
BR0007553A (pt) Derivados de 2,3-o-isopropilideno demonossacarìdeos com atividade inibidora deaderência celular
CZ290784B6 (cs) Pyrido[3,2-e]pyrazinony, způsoby jejich výroby a pouľití a farmaceutické přípravky na jejich bázi
HUP0100394A2 (hu) 2-es Helyzetben fenil-szubsztituenst hordozó imidazo-triazinon-származékok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények
BR0311605A (pt) Compostos de amida de ácido 3-aminotieno[2,3-b]piridina-2-carboxìlico substituìdo e processos para preparação e seus usos
EP1913004B1 (en) 8-methoxy-9h-isothiazolo[5,4-b]quinoline-3,4-diones and related compounds as anti-infective agents
DK157861C (da) Analogifremgangsmaade til fremstilling af 4-substituerede fenylalkylimidazolderivater eller ugiftige, farmaceutisk acceptable syreadditionssalte deraf
SI1077218T1 (sl) Peptido-mimetiäśne spojine, ki vsebujejo sekvenco rgd, uporabne kot inhibitorji integrinov
Groutas et al. Substituted 3-oxo-1, 2, 5-thiadiazolidine 1, 1-dioxides: a new class of potential mechanism-based inhibitors of human leukocyte elastase and cathepsin G
DK164855B (da) Spergualin-beslaegtede forbindelser med en phenylengruppe, fremgangsmaade til fremstilling deraf samt en farmaceutisk sammensaetning
EP0024347B1 (en) Organic sulfoxides having a latent allyl group, process for preparing the same and pharmaceutical enzyme inhibiting composition comprising the same
IE57835B1 (en) 7-acylamino mitosanes
Thomas et al. 7-Glycosylpurines. II. Arabinofuranosides of Hypoxanthine and Adenine1
KOBASHI et al. Therapy for urolithiasis by hydroxamic acids. II. Urease inhibitory potency and urinary excretion rate of hippurohydroxamic acid derivatives
EP2938623B1 (en) Selected macrolides with pde4-inhibiting activity
PL149156B1 (en) Method of obtaining novel /3s(z)/-2///1-(2-amino-4-thiazolilo/-2-//2,2-dimethyl-4-keto-1-/sulfoxy/-3-azetidinyl/-amino/-2-ketoethylideno/-amino/-oxy/-acetic acid
CA1234813A (en) Cyclic prodrugs of antiinflammatory oxicams
EP1809639B1 (en) 8a, 9-dihydro-4a-h-isothiazolo[5,4-b] quinoline-3, 4-diones and related compounds as anti-infective agents
US3120509A (en) Process for the manufacture of vitamins of the group b
Padmavathi et al. A new class of sulfur‐linked bis‐1, 2, 3‐selenadiazoles, 1, 2, 3‐thiadiazoles, and 2H‐diazaphospholes
Reid et al. Chemical modification of aminoglycosides. 3. Synthesis of 2"-deoxykanamycins from neamine
Ashton et al. Irreversible enzyme inhibitors. 198. Diaminodihydro-s-triazines and diaminopyrimidines bearing substituted (ureidomethyl) phenyl substituents as reversible inhibitors of dihydrofolate reductase
JP2005154342A (ja) トポイソメラーゼ阻害剤
CN117586237A (zh) 一种urat1抑制剂及其用途
Valuev-Elliston et al. Synthesis and studies of new 6-[halo (diphenyl) methyl]-and 6-(thiophen-2-ylmethyl) pyrimidin-4 (3 H)-ones as possible HIV-1 reverse transcriptase inhibitors
SE446340B (sv) Sett att framstella halvsyntetiska 4"-sulfonylamino-oleandomycinderivat

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A E 9A ANUIDADES

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 NA RPI2003 DE 26/05/2009.